메뉴 건너뛰기




Volumn 15, Issue 6, 2011, Pages 893-899

Effect of the antiplatelet agent cilostazol on endovascular inflammatory biochemical parameters and the clinical symptoms of peripheral artery disease and restless legs syndrome in hemodialysis patients

Author keywords

Cilostazol; Peripheral artery disease; Restless legs syndrome

Indexed keywords

CILOSTAZOL; HIGH DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; VON WILLEBRAND FACTOR;

EID: 84855263232     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-011-0485-2     Document Type: Article
Times cited : (3)

References (22)
  • 1
    • 0016403709 scopus 로고
    • Accelerated atherosclerosis in prolonged maintenance hemodialysis
    • 4813742 1:STN:280:DyaE2c7gtlGiuw%3D%3D
    • A Lindner B Charra DJ Sherrard BH Scribner 1974 Accelerated atherosclerosis in prolonged maintenance hemodialysis N Engl J Med 290 697 701 4813742 1:STN:280:DyaE2c7gtlGiuw%3D%3D
    • (1974) N Engl J Med , vol.290 , pp. 697-701
    • Lindner, A.1    Charra, B.2    Sherrard, D.J.3    Scribner, B.H.4
  • 2
    • 0035187621 scopus 로고    scopus 로고
    • Coronary artery disease in uremia: Etiology, diagnosis, and therapy
    • DOI 10.1046/j.1523-1755.2001.00040.x
    • DJ Goldsmith A Covic 2001 Coronary artery disease in uremia: etiology, diagnosis, and therapy Kidney Int 60 2059 2078 11737581 1:STN:280: DC%2BD3MnovFyitg%3D%3D (Pubitemid 33070450)
    • (2001) Kidney International , vol.60 , Issue.6 , pp. 2059-2078
    • Goldsmith, D.J.A.1    Covic, A.2
  • 3
    • 0035199665 scopus 로고    scopus 로고
    • Lower-extremity peripheral arterial disease among patients with end-stage renal disease
    • A O'Hare K Johansen 2001 Lower-extremity peripheral arterial disease among patients with end-stage renal disease J Am Soc Nephrol 12 2838 2847 11729255 (Pubitemid 33115433)
    • (2001) Journal of the American Society of Nephrology , vol.12 , Issue.12 , pp. 2838-2847
    • O'Hare, A.1    Johansen, K.2
  • 5
    • 0033610236 scopus 로고    scopus 로고
    • A new pharmacological treatment for intermittent claudication: Results of a randomized, multicenter trial
    • DOI 10.1001/archinte.159.17.2041
    • HG Beebe DL Dawson BS Cutler JA Herd DE Strandness Jr EB Bortey, et al. 1999 A new pharmacological treatment for intermittent claudication: results of a randomized, multicenter trial Arch Intern Med 159 2041 2050 10510990 1:CAS:528:DyaK1MXms12mtr0%3D (Pubitemid 29453592)
    • (1999) Archives of Internal Medicine , vol.159 , Issue.17 , pp. 2041-2050
    • Beebe, H.G.1    Dawson, D.L.2    Cutler, B.S.3    Herd, J.A.4    Strandness Jr., D.E.5    Bortey, E.B.6    Forbes, W.P.7
  • 7
    • 36048954100 scopus 로고
    • Clinical evaluation of OPC-13013, a new platelet aggregation inhibitor, or chronic arterial occlusive diseases: Dose finding study by double-blind method
    • M Yoshio T Tatsuzou Y Yoshihide K Sakuzou K Teruhisa W Masahiko, et al. 1986 Clinical evaluation of OPC-13013, a new platelet aggregation inhibitor, or chronic arterial occlusive diseases: dose finding study by double-blind method Clin Eval 14 13 41
    • (1986) Clin Eval , vol.14 , pp. 13-41
    • Yoshio, M.1    Tatsuzou, T.2    Yoshihide, Y.3    Sakuzou, K.4    Teruhisa, K.5    Masahiko, W.6
  • 8
    • 0022541684 scopus 로고
    • Dialysis membranes and coagulation system
    • M Notohamiprodjo K Andrassy J Bommer E Ritz 1986 Dialysis membranes and coagulation system Blood Purif 4 130 141 2942155 1:CAS:528:DyaL28XksFyrt7Y%3D (Pubitemid 16079377)
    • (1986) Blood Purification , vol.4 , Issue.1-3 , pp. 130-141
    • Notohamiprodjo, M.1    Andrassy, K.2    Bommer, J.3    Ritz, E.4
  • 10
    • 0031836608 scopus 로고    scopus 로고
    • Role of cyclic adenosine monophosphate in reducing superoxide anion generation in guinea pig alveolar macrophages
    • DOI 10.1159/000028219
    • K Takei K Tokuyama M Kato A Morikawa 1998 Role of cyclic adenosine monophosphate in reducing superoxide anion generation in guinea pig alveolar macrophages Pharmacology 57 1 7 9670206 1:CAS:528:DyaK1cXktlKisbc%3D (Pubitemid 28288862)
    • (1998) Pharmacology , vol.57 , Issue.1 , pp. 1-7
    • Takei, K.1    Tokuyama, K.2    Kato, M.3    Morikawa, A.4
  • 12
    • 0032856493 scopus 로고    scopus 로고
    • Inhibition of the p53 tumor suppressor gene results in growth of human aortic vascular smooth muscle cells: Potential role of p53 in regulation of vascular smooth muscle cell growth
    • M Aoki R Morishita H Matsushita S Hayashi H Nakagami K Yamamoto, et al. 1999 Inhibition of the p53 tumor suppressor gene results in growth of human aortic vascular smooth muscle cells. Potential role of p53 in regulation of vascular smooth muscle cell Hypertension 34 2 192 200 10454440 1:CAS:528:DyaK1MXlvFGmtLk%3D (Pubitemid 29409214)
    • (1999) Hypertension , vol.34 , Issue.2 , pp. 192-200
    • Aoki, M.1    Morishita, R.2    Matsushita, H.3    Hayashi, S.-I.4    Nakagami, H.5    Yamamoto, K.6    Moriguchi, A.7    Kaneda, Y.8    Higaki, J.9    Ogihara, T.10
  • 13
    • 0034883805 scopus 로고    scopus 로고
    • Inhibition of neointimal formation after balloon injury by cilostazol, accompanied by improvement of endothelial dysfunction and induction of hepatocyte growth factor in rat diabetes model
    • DOI 10.1007/s001250100593
    • M Aoki R Morishita S Hayashi N Jo K Matsumoto T Nakamura, et al. 2001 Inhibition of neointimal formation after balloon injury by cilostazol, accompanied by improvement of endothelial dysfunction and induction of hepatocyte growth factor in rat diabetes model Diabetologia 44 1034 1042 11484082 1:CAS:528:DC%2BD3MXlsFCgsbw%3D (Pubitemid 32778137)
    • (2001) Diabetologia , vol.44 , Issue.8 , pp. 1034-1042
    • Aoki, M.1    Morishita, R.2    Hayashi, S.3    Jo, N.4    Matsumoto, K.5    Nakamura, T.6    Kaneda, Y.7    Ogihara, T.8
  • 14
    • 4644287449 scopus 로고    scopus 로고
    • Cilostazol inhibits leukocyte integrin Mac-1, leading to a potential reduction in restenosis after coronary stent implantation
    • DOI 10.1016/j.jacc.2004.06.066, PII S0735109704014421
    • T Inoue T Uchida M Sakuma Y Imoto Y Ozeki Y Ozaki, et al. 2004 Cilostazol inhibits leukocyte integrin Mac-1, leading to a potential reduction in restenosis after coronary stent implantation J Am Coll Cardiol 44 1408 1414 15464320 1:CAS:528:DC%2BD2cXot1WqtL4%3D (Pubitemid 39303941)
    • (2004) Journal of the American College of Cardiology , vol.44 , Issue.7 , pp. 1408-1414
    • Inoue, T.1    Uchida, T.2    Sakuma, M.3    Imoto, Y.4    Ozeki, Y.5    Ozaki, Y.6    Hikichi, Y.7    Node, K.8
  • 15
    • 64949096705 scopus 로고    scopus 로고
    • The vascular and biochemical effects of cilostazol in patients with peripheral arterial disease
    • EO Mark AB Stephen AS Mohammed SY Ian L Bernard VS Chee 2009 The vascular and biochemical effects of cilostazol in patients with peripheral arterial disease J Vasc Surg 49 5 1226 1234
    • (2009) J Vasc Surg , vol.49 , Issue.5 , pp. 1226-1234
    • Mark, E.O.1    Stephen, A.B.2    Mohammed, A.S.3    Ian, S.Y.4    Bernard, L.5    Chee, V.S.6
  • 16
    • 58149461846 scopus 로고    scopus 로고
    • Activation of tyrosine hydroxylase prevents pneumonia in a rat chronic cerebral hypoperfusion model
    • 19032975 1:CAS:528:DC%2BD1MXns12jtA%3D%3D
    • N Zhang N Miyamoto R Tanaka H Mochizuki N Hattori T Urabe 2009 Activation of tyrosine hydroxylase prevents pneumonia in a rat chronic cerebral hypoperfusion model Neuroscience 158 665 672 19032975 1:CAS:528: DC%2BD1MXns12jtA%3D%3D
    • (2009) Neuroscience , vol.158 , pp. 665-672
    • Zhang, N.1    Miyamoto, N.2    Tanaka, R.3    Mochizuki, H.4    Hattori, N.5    Urabe, T.6
  • 19
    • 66049104209 scopus 로고    scopus 로고
    • Peripheral arterial disease: Pathophysiology, risk factors, diagnosis, treatment, and prevention
    • RL Muri 2009 Peripheral arterial disease: Pathophysiology, risk factors, diagnosis, treatment, and prevention J Vasc Nurs 27 2 26 30
    • (2009) J Vasc Nurs , vol.27 , Issue.2 , pp. 26-30
    • Muri, R.L.1
  • 20
    • 43249105908 scopus 로고    scopus 로고
    • Cilostazol as an alternative to aspirin after ischaemic stroke: A randomized, double-blind, pilot study
    • Huang Y, Cheng Y, Wu J, Li Y, Xu E, Hong Z, et al. Cilostazol as an alternative to aspirin after ischaemic stroke: a randomized, double-blind, pilot study. Lancet Neurol. 2008;7:494-9.
    • (2008) Lancet Neurol , vol.7 , pp. 494-499
    • Huang, Y.1    Cheng, Y.2    Wu, J.3    Li, Y.4    Xu, E.5    Hong, Z.6
  • 21
    • 0342955606 scopus 로고    scopus 로고
    • Effects of cilostazol on angiographic restenosis after coronary stent replacement
    • 11009265 1:CAS:528:DC%2BD3cXlvV2ku78%3D
    • SW Park CW Lee HS Kim NH Lee DY Nah MK Hong, et al. 2000 Effects of cilostazol on angiographic restenosis after coronary stent replacement Am J Cardiol 86 499 503 11009265 1:CAS:528:DC%2BD3cXlvV2ku78%3D
    • (2000) Am J Cardiol , vol.86 , pp. 499-503
    • Park, S.W.1    Lee, C.W.2    Kim, H.S.3    Lee, N.H.4    Nah, D.Y.5    Hong, M.K.6
  • 22
    • 16844369688 scopus 로고    scopus 로고
    • Cilostazol prevents the progression of the symptomatic intracranial arterial stenosis: The multicenter double-blind placebo-controlled trial of cilostazol in symptomatic intracranial arterial stenosis
    • 15746463 1:CAS:528:DC%2BD2MXislait7Y%3D
    • SU Kwon YJ Cho JS Koo HJ Bae YS Lee KS Hong, et al. 2005 Cilostazol prevents the progression of the symptomatic intracranial arterial stenosis: the multicenter double-blind placebo-controlled trial of cilostazol in symptomatic intracranial arterial stenosis Stroke 36 782 786 15746463 1:CAS:528: DC%2BD2MXislait7Y%3D
    • (2005) Stroke , vol.36 , pp. 782-786
    • Kwon, S.U.1    Cho, Y.J.2    Koo, J.S.3    Bae, H.J.4    Lee, Y.S.5    Hong, K.S.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.